Main public logs

Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 13:48, 5 July 2024 JDoerfler talk contribs created page Publication: Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation (Created page with "{{Publication |Title=Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation |Topic=Vitamin E |Author=Ghoreishi, Z; Shidfar, F; Iravani, M; Esfahani, A; Ghavamzadeh, A |Year=2007 |Journal=Asia-Pacific Journal of Clinical Oncology |DOI=https://10.1111/j.1743-7563.2007.00111.x |Authors Abstract=Aim: This study was conducted to investigate the effect of oral vitamin E on mucositis and neutropenia in p...")
• 12:34, 5 July 2024 JDoerfler talk contribs created page Ferreira et al. (2004): Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial (Created page with "{{Reference |Reference=Publication: Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial }} {{Study Note}} =Brief summary= In this study, patients with head and neck tumors were divided into two different arms before radiotherapy. One arm received additional vitamin E throughout the radiotherapy and the other arm only a placebo. There were significantly fewer cases of oral mucositis (i.e. inflammation...")
• 12:10, 5 July 2024 JDoerfler talk contribs created page Publication: Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial (Created page with "{{Publication |Title=Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial |Topic=Vitamin E |Author=Ferreira, PR; Fleck, JF; Diehl, A; Barletta, D; Braga-Filho, A; Barletta, A; Ilha, L |Year=2004 |Journal=Head and Neck |DOI=https://10.1002/hed.10382 |Authors Abstract=Abstract: Background. The study was designed to test whether vitamin E (VE) provides oral mucosal protection in patients with irradiated c...")
• 11:29, 5 July 2024 JDoerfler talk contribs created page Fallahi et al. (2013): Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? (Created page with "{{Reference |Reference=Publication: Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on an...")
• 11:21, 5 July 2024 JDoerfler talk contribs created page Publication: Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? (Created page with "{{Publication |Title=Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? |Topic=Vitamin E |Author=Fallahi, B; Beiki, D; Abedi, SM; Saghari, M; Fard-Esfahani, A; Akhzari, F; Mokarami, B; Eftekhari, M |Year=2013 |Journal=Nuclear medicine communications |DOI=https://10.1097/MNM.0b013e328362b1f2 |Authors Abstract=Objectives Salivary gland impairment after high-dose radioiodine (131I) treatment is well recognized. The aim of thi...")
• 09:22, 5 July 2024 JDoerfler talk contribs created page Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis (Created page with "{{Reference |Reference=Publication: Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-9...")
• 09:21, 5 July 2024 JDoerfler talk contribs created page Publication: Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis (Created page with "{{Publication |Title=Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis |Topic=Vitamin E |Author=Delanian, S; Porcher, R; Balla-Mekias, S; Lefaix, J-L |Year=2003 |Journal=Journal of clinical Oncology |DOI=https://10.1200/JCO.2003.06.064 |Authors Abstract=Purpose: Radiation-induced fibrosis (RIF) is a rare morbid complication of radiotherapy, without an established method of management. R...")
• 14:27, 4 July 2024 JDoerfler talk contribs created page Barton et al. (1998): Prospective evaluation of vitamin E for hot flashes in breast cancer survivors (Created page with "{{Reference |Reference=Publication: Prospective evaluation of vitamin E for hot flashes in breast cancer survivors }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries o...")
• 14:26, 4 July 2024 JDoerfler talk contribs created page Publication: Prospective evaluation of vitamin E for hot flashes in breast cancer survivors (Created page with "{{Publication |Title=Prospective evaluation of vitamin E for hot flashes in breast cancer survivors |Topic=Vitamin E |Author=Barton, DL; Loprinzi, CL; Quella, SK; Sloan, JA; Veeder, MH; Egner, JR; Fidler, P; Stella, PJ; Swan, DK; Vaught, NL; Novotny, P |Year=1998 |Journal=Journal of clinical Oncology |DOI=https://doi.org/10.1200/JCO.1998.16.2.495 |Authors Abstract=Purpose Hot flashes are a significant issue for many breast cancer survivors, with concerns over the use of...")
• 14:18, 4 July 2024 JDoerfler talk contribs created page Bairati et al. (2005): A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients (Created page with "{{Reference |Reference=Publication: A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specificat...")
• 14:17, 4 July 2024 JDoerfler talk contribs created page Publication: A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients (Created page with "{{Publication |Title=A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients |Topic=Vitamin E |Author=Bairati, I; Meyer, F; Gélinas, M; Fortin, A; Nabid, A; Brochet, F; Mercier, J. P; Têtu, B; Harel, F; Mâsse, B; Vigneault, É; Vass, S; del Vecchio, P; Roy, J |Year=2005 |Journal=Journal of the National Cancer Institute |DOI=https://10.1093/jnci/dji095 |Authors Abstract=Background: Although low dietary intakes of an...")
• 13:37, 4 July 2024 JDoerfler talk contribs created page Azizi et al. (2015): Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis (Created page with "{{Reference |Reference=Publication: Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=...")
• 13:37, 4 July 2024 JDoerfler talk contribs created page Publication: Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis (Created page with "{{Publication |Title=Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis |Topic=Vitamin E |Author=Azizi, A; Alirezaei, S; Pedram, P; Mafi, AR |Year=2015 |Journal=Reports of Radiotherapy and Oncology |DOI=https://0.5812/rro.2(1)2015.796 |Authors Abstract=Background: There is still no consensus regarding the optimum treatment of chemotherapy-induced oral mucositis, and its management is still mainly supportive. Vitamin E has been sh...")
• 13:09, 4 July 2024 JDoerfler talk contribs created page Argyriou et al. (2006): Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation (Created page with "{{Reference |Reference=Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |E...")
• 13:08, 4 July 2024 JDoerfler talk contribs created page Publication: Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation (Created page with "{{Publication |Title=Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Journal of Pain and Symptom Management |DOI=https://10.1016/j.jpainsymman.2006.03.013 |Authors Abstract=A randomized, controlled trial was performed to assess the efficacy and safety of vitamin E supplement...")
• 11:30, 4 July 2024 JDoerfler talk contribs created page Argyriou et al. (2006): A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results (Created page with "{{Reference |Reference=? }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Outcome timeline=? }} =Characteristics of participants= {{Cha...")
• 11:29, 4 July 2024 JDoerfler talk contribs deleted page Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results (content was: "{{Publication |Title=A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Supportive care in cancer |DOI...", and the only contributor was "JDoerfler" (talk))
• 11:29, 4 July 2024 JDoerfler talk contribs created page Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results (Created page with "{{Publication |Title=A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Supportive care in cancer |DOI=https://10.1007/s00520-006-0072-3 |Authors Abstract=Aim: A randomized, open-label with blind assessme...")
• 11:26, 4 July 2024 JDoerfler talk contribs created page Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results (Created page with "{{Publication |Title=A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Supportive care in cancer |DOI=https://10.1007/s00520-006-0072-3 |Authors Abstract=Aim: A randomized, open-label with blind assessme...")
• 13:16, 1 July 2024 JDoerfler talk contribs deleted page Pubclivation: TItel STudie (content was: "{{Publication |Title=5 |Topic=Zeolites |Author=re |Year=34 |Journal=rh |Authors Abstract=? }}", and the only contributor was "JDoerfler" (talk))
• 13:16, 1 July 2024 JDoerfler talk contribs deleted page Syrh (content was: "{{Reference |Reference=Pubclivation: TItel STudie }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Coun...", and the only contributor was "JDoerfler" (talk))
• 13:08, 1 July 2024 JDoerfler talk contribs created page Pubclivation: TItel STudie (Created page with "{{Publication |Title=5 |Topic=Zeolites |Author=re |Year=34 |Journal=rh |Authors Abstract=? }}")
• 13:04, 1 July 2024 JDoerfler talk contribs created page Syrh (Created page with "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Outcome timeline=? }} =Characteristics of participants= {{Characteristics of participants |...")
• 12:20, 25 June 2024 JDoerfler talk contribs created page Afonseca et al. (2013): Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial (Created page with "{{Reference |Reference=Publication: Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of da...")
• 12:19, 25 June 2024 JDoerfler talk contribs created page Publication: Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial (Created page with "{{Publication |Title=Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial |Topic=Vitamin E |Author=Afonseca, SOd; Cruz, FM; Cubero, DDdlG; Lera, AT; Schindler, F; Okawara, M; Souza, LFd; Rodrigues, NP; Giglio, Ad |Year=2013 |Journal=Sao Paulo Medical Journal |DOI=https://doi.org/10.1590/S1516-31802013000100006 |Authors Abstract=CONTEXT AND OBJECTIVE Oxaliplatin is one of the chemotherapy regimens most used for treating...")
• 08:03, 25 June 2024 JDoerfler talk contribs created page Büntzel et al. (2010): Selenium Substitution During Radiotherapy of Solid Tumours - Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients (Created page with "{{Reference |Reference=Publication: Selenium substitution during radiotherapy of solid tumours Laboratory data from two observation studies in gynaecological and head and neck cancer patients }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analys...")
• 08:02, 25 June 2024 JDoerfler talk contribs deleted page Büntzel et al. (2010): Selenium substitution during radiotherapy of solid tumors (content was: "{{Reference |Reference=Publication: Selenium substitution during radiotherapy of solid tumors }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |An...", and the only contributor was "JDoerfler" (talk))
• 08:00, 25 June 2024 JDoerfler talk contribs created page Büntzel et al. (2010): Selenium substitution during radiotherapy of solid tumors (Created page with "{{Reference |Reference=Publication: Selenium substitution during radiotherapy of solid tumors }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Outcome timeline=? }} =...")
• 11:57, 17 June 2024 JDoerfler talk contribs created page Publication: Selenium Substitution During Radiotherapy of Solid Tumours Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients (Created page with "{{Publication |Title=Selenium Substitution During Radiotherapy of Solid Tumours Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients |Topic=Selenium |Author=Büntzel, J; Micke, O; Kisters, K; Bruns, F; Glatzel, M; Schänekaes, K; Kundt, C; Schäfer, U; Mücke, R |Year=2010 |Journal=Anticancer Research |DOI=https://ar.iiarjournals.org/content/30/5/1783.short |Authors Abstract=Objective: Selenium is an essential cofactor of the e...")
• 12:43, 14 June 2024 JDoerfler talk contribs created page Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization (Created page with "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusio...")
• 12:42, 14 June 2024 JDoerfler talk contribs created page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization |Topic=Selenium |Author=Muecke, R; Micke, O; Schomburg, L; Glatzel, M; Reichl, B; Kisters, K; Schaefer, U; Huebner, J; Eich, HT; Fakhrian, K; Adamietz, IA; Buentzel, J |Year=2014 |Journal=Integrative Cancer Therapies |DOI=10.1177/1534735414541963 |Authors Abs...")
• 12:14, 14 June 2024 JDoerfler talk contribs created page Muecke et al. (2013): Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial (Created page with "{{Reference |Reference=Publication: Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion crite...")
• 12:11, 14 June 2024 JDoerfler talk contribs created page Publication: Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial (Created page with "{{Publication |Title=Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial |Topic=Selenium |Author=Muecke, R; Micke, O; Schomburg, L; Buentzel, J; Glatzel, M; Baaske, D; Berndt-Skorka, R; Prott, FJ; Reichl, B; Kisters, K; Schaefer, U; Huebner, J; Eich, HT; Kundt, G; Adamietz, IA |Year=2013 |Journal=Radiation Oncology...")
• 07:52, 13 June 2024 JDoerfler talk contribs created page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countri...")
• 07:49, 13 June 2024 JDoerfler talk contribs created page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=doi:10.1016/j.ijrobp.2009.08.013 |A...")
• 14:14, 11 June 2024 JDoerfler talk contribs created page Mix et al. (2015): Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck (Created page with "{{Reference |Reference=Publication: Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=?...")
• 14:03, 11 June 2024 JDoerfler talk contribs created page Publication: Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck (Created page with "{{Publication |Title=Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck |Topic=Selenium |Author=Mix, M; Singh, AK; Tills, M; Dibaj, S; Groman, A; Jaggernauth, W; Rustum, Y; Jameson, M B |Year=2015 |Journal=World journal of clinical oncology |DOI=10.5306/wjco.v6.i5.166 |Authors Abstract=AIM: To investigate whether selenomethionine (SLM) reduces mucositis incidence in patie...")
• 06:54, 11 June 2024 JDoerfler talk contribs created page Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 (Created page with "{{Reference |Reference=Publication: Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N r...")
• 13:17, 10 June 2024 JDoerfler talk contribs created page Publication: Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 (Created page with "{{Publication |Title=Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 |Topic=Selenium |Author=Karp, D. D.; Lee, S. J.; Keller, S. M.; Wright, G. S.; Aisner, S.; Belinsky, S. A.; Johnson, D. H.; Johnston, M. R.; Goodman, G.; Clamon, G.; Okawara, G.; Marks, R.; Frechette, E.; McCaskill-Stevens, W.; Lippman, S. M.; Ruckdeschel, J.; Khuri, F. R. |Y...")
• 08:25, 10 June 2024 JDoerfler talk contribs created page Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial (Created page with "{{Reference |Reference=Publication: The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analy...")
• 08:22, 10 June 2024 JDoerfler talk contribs created page Publication: The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial (Created page with "{{Publication |Title=The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial |Topic=Selenium |Author=Jahangard-Rafsanjani, Z.; Gholami, K.; Hadjibabaie, M.; Shamshiri, A.R.; Alimoghadam, K.; Sarayani, A.; Mojtahedzadeh, M.; Ostadali-Dehaghi, M.; Ghavamzadeh, A. |Year=2013 |Journal=Bone marrow transplantation |DOI=10.1038/bmt.2012.250 |Authors Abstract=Oral mucositis (OM) is a complication of high-dose...")
• 11:26, 7 June 2024 JDoerfler talk contribs deleted page Tj (content was: "{{Publication |Title=xfj |Topic=FactorAF2 |Author=hf |Year=2015 |Journal=cgj |Authors Abstract=Background }}", and the only contributor was "JDoerfler" (talk))
• 11:25, 7 June 2024 JDoerfler talk contribs created page Tj (Created page with "{{Publication |Title=xfj |Topic=FactorAF2 |Author=hf |Year=2015 |Journal=cgj |Authors Abstract=Background }}")
• 11:24, 7 June 2024 JDoerfler talk contribs created page Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial (Created page with "{{Reference |Reference=Publication: Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N rand...")
• 10:46, 7 June 2024 JDoerfler talk contribs created page Publication: Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial (Created page with "{{Publication |Title=Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial |Topic=Selenium |Author=Goossens, M.E.; Zeegers, M.P.; van Poppel, H.; Joniau, S.; Ackaert, K.; Ameye, F.; Billiet, I.; Braeckman, J.; Breugelmans, A.; Darras, J.; Dilen, K.; Goeman, L.; Tombal, B.; Van Bruwaene, S.; Van Cleyenbreugel, B.; Van der Aa, F.; Vekemans, K.; Buntinx, F. |Year=2016 |Journal=E...")
• 09:31, 7 June 2024 JDoerfler talk contribs created page Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients (Created page with "{{Reference |Reference=Publication: Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specific...")
• 09:29, 7 June 2024 JDoerfler talk contribs created page Publication: Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients (Created page with "{{Publication |Title=Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients |Topic=Selenium |Author=Büntzel, J.; Riesenbeck, D.; Glatzel, M.; Berndt-Skorka, R.; Riedel, T.; Mücke, R.; Kisters, K.; Schönekaes, K.G.; Schäfer, U.; Bruns, F.; Micke, O. |Year=2010 |Journal=Anticancer research |Authors Abstract=Objective: The substitution of selenium activates the selenium-dependent enzy...")
• 07:33, 4 June 2024 JDoerfler talk contribs created page Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients (Created page with "{{Reference |Reference=Publication: Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |...")
• 07:31, 4 June 2024 JDoerfler talk contribs created page Publication: Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients (Created page with "{{Publication |Title=Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients |Topic=Selenium |Author=I. A. Asfour; S. El Shazly; M. H. Fayek; H. M. Hegab; S. Raouf; M. A. R. Moussa |Year=2006 |Journal=Biological trace element research |DOI=10.1385/bter:110:1:19 |Authors Abstract=The present study was undertaken to explore the effect of the administration of high doses of sodium selenite on apoptosis in polym...")
• 06:26, 4 June 2024 JDoerfler talk contribs created page Stratton et al. (2010): Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer (Created page with "{{Reference |Reference=Publication: Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=?...")